QTHLF (Quantum Healthcare) EV-to-EBITDA: -42.21 (As of Aug. 02, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Quantum Healthcare EV-to-EBITDA?

Quantum Healthcare QTHLF +20.00% EV-to-EBITDA is -42.21 as of Aug. 02, 2026. The stock has 3 warning signs investors should review. Among 512 Medical Devices & Instruments companies, Quantum Healthcare ranks worse than 195312.3% on this metric.

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Quantum Healthcare's enterprise value is $21.57 Mil. Quantum Healthcare's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.51 Mil. Therefore, Quantum Healthcare's EV-to-EBITDA for today is -42.21.

The historical rank and industry rank for Quantum Healthcare's EV-to-EBITDA or its related term are showing as below:

QTHLF' s EV-to-EBITDA Range Over the Past 10 Years
Min: -191.25   Med: -1.12   Max: 1.89
Current: -41.69

During the past 13 years, the highest EV-to-EBITDA of Quantum Healthcare was 1.89. The lowest was -191.25. And the median was -1.12.

QTHLF's EV-to-EBITDA is ranked worse than
100% of 512 companies
in the Medical Devices & Instruments industry
Industry Median: 14.39 vs QTHLF: -41.69

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2026-08-02), Quantum Healthcare's stock price is $0.0006. Quantum Healthcare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $0.000. Therefore, Quantum Healthcare's PE Ratio (TTM) for today is N/A.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Quantum Healthcare  (OTCPK:QTHLF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Quantum Healthcare's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0006/0.000
=N/A

Quantum Healthcare's share price for today is $0.0006.
Quantum Healthcare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Quantum Healthcare EV-to-EBITDA Related Terms


Quantum Healthcare EV-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Quantum Healthcare's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quantum Healthcare EV-to-EBITDA Chart

Quantum Healthcare Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.67 -6.15 -14.86 -75.61 -21.35

Quantum Healthcare Quarterly Data
Jun20 Sep20 Dec20 Jun21 Sep21 Dec21 Jun22 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -909.74 94.61 34.96 -21.35 -22.81

QTHLF vs ABT, SYK, MDT: EV-to-EBITDA Comparison

For the Medical Devices subindustry, Quantum Healthcare's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Quantum Healthcare EV-to-EBITDA vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Quantum Healthcare's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Quantum Healthcare's EV-to-EBITDA falls into.



Quantum Healthcare EV-to-EBITDA Calculation

Quantum Healthcare's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=21.569/-0.511
=-42.21

Quantum Healthcare's current Enterprise Value is $21.57 Mil.
Quantum Healthcare's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.51 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EV-to-EBITDA →
What does a EV-to-EBITDA of -42.21 mean?
Quantum Healthcare (QTHLF) has a EV-to-EBITDA of -42.21 as of Aug. 02, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Quantum Healthcare. According to the industry distribution chart, Quantum Healthcare ranks #999999 out of 512 companies in the Medical Devices & Instruments industry.
Is Quantum Healthcare's EV-to-EBITDA too high?
Quantum Healthcare's current EV-to-EBITDA is -42.21. Based on the distribution chart, Quantum Healthcare ranks #999999 out of 512 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Quantum Healthcare's EV-to-EBITDA compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Quantum Healthcare ranks #999999 out of 512 companies for EV-to-EBITDA. This places Quantum Healthcare in the lower half of its industry. The industry median EV-to-EBITDA is 14.39. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.39, based on 512 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Quantum Healthcare. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Quantum Healthcare's current EV-to-EBITDA is -42.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quantum Healthcare stock overvalued right now?
Quantum Healthcare (QTHLF) has a current EV-to-EBITDA of -42.21. The current EV-to-EBITDA is -42.21. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Quantum Healthcare (QTHLF), the current EV-to-EBITDA is -42.21 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Quantum Healthcare Business Description

Other Exchanges V8Y:Singapore
Address 745 Lorong 5 Toa Payoh, Suite 01-00, Singapore, SGP, 319455
Quantum Healthcare Ltd formerly QT Vascular Ltd engages in the development and distribution of therapeutic solutions for the treatment of vascular diseases. It designs, assembles, and distributes therapeutic solutions for the minimally invasive treatment of complex vascular diseases. Healthcare Business also includes the provision of dental services, and Corporate business includes operations management and consultancy services. Company provides services which includes the research, development, and design of medical equipment and other related products of geriatric medical rehabilitation equipment and others.